Harvest Group Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,258
Closed -$44K 483
2020
Q4
$44K Buy
1,258
+166
+15% +$5.74K 0.03% 110
2020
Q3
$38K Hold
1,092
0.03% 108
2020
Q2
$35K Hold
1,092
0.03% 106
2020
Q1
$32K Hold
1,092
0.03% 99
2019
Q4
$31K Hold
1,092
0.03% 113
2019
Q3
$28K Hold
1,092
0.03% 122
2019
Q2
$27K Hold
1,092
0.03% 119
2019
Q1
$29K Buy
+1,092
New +$26.8K 0.03% 126

Other funds holding NVO

Harvest Group Wealth Management's NVO Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Novo Nordisk (NVO) in Q1 2021, closing a stake of 1,258 shares — an estimated $44K sold.

Harvest Group Wealth Management first reported a position in NVO in Q1 2019 and held it in 8 quarters. The position peaked at $44K in Q4 2020. 707 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining Novo Nordisk position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 1,258 Novo Nordisk shares in Q1 2021, an estimated $44K.
  • Harvest Group Wealth Management first reported a position in Novo Nordisk in Q1 2019 and held it in 8 quarters.
  • Harvest Group Wealth Management's Novo Nordisk position peaked at $44K in Q4 2020.
  • 707 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.